The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Autoimmune Epilepsy: Clinical Characteristics and Response to Immunotherapy
Open accessAbstract
OBJECTIVE: To describe clinical characteristics and immunotherapy responses in patients with autoimmune epilepsy. DESIGN: Observational, retrospective case series. SETTING: Mayo Clinic Health System. PATIENTS: Thirty-two patients with an exclusive (n=11) or predominant (n=21) seizure presentation in whom an autoimmune etiology was suspected (on the basis of neural autoantibody [91%], inflammatory cerebrospinal fluid [31%], or magnetic resonance imaging suggesting inflammation [63%]) were studied. All had partial seizures: 81% had failed treatment with 2 or more antiepileptic drugs and had daily seizures and 38% had seizure semiologies that were multifocal or changed with time. Head magnetic resonance imaging was normal in 15 (47%) at onset. Electroencephalogram abnormalities included interictal epileptiform discharges in 20; electrographic seizures in 15; and focal slowing in 13. Neural autoantibodies included voltage-gated potassium channel complex in 56% (leucine-rich, glioma-inactivated 1 specific, 14; contactin-associated proteinlike 2 specific, 1); glutamic acid decarboxylase 65 in 22%; collapsin response- mediator protein 5 in 6%; and Ma2, N-methyl-D-aspartate receptor, and ganglionic acetylcholine receptor in 1 patient each. INTERVENTION: Immunotherapy with intravenous methylprednisolone; intravenous immune globulin; and combinations of intravenous methylprednisolone, intravenous immune globulin, plasmapheresis, or cyclophosphamide. MAIN OUTCOME MEASURE: Seizure frequency. RESULTS: After a median interval of 17 months (range, 3-72 months), 22 of 27 (81%) reported improvement postimmunotherapy; 18 were seizure free. The median time from seizure onset to initiating immunotherapy was 4 months for responders and 22 months for nonresponders (P<.05). All voltage-gated potassium channel complex antibody-positive patients reported initial or lasting benefit (P<.05). One voltage-gated potassium channel complex antibody-positive patient was seizure free after thyroid cancer resection; another responded to antiepileptic drug change alone. CONCLUSION: When clinical and serological clues suggest an autoimmune basis for medically intractable epilepsy, early-initiated immunotherapy may improve seizure outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early Identification of Refractory Epilepsy
Kwan, P., & Brodie, M. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002033420503 · Cited by 5,204
Berg, A. T., Berkovic, S. F., Brodie, M. J., Buchhalter, J., Cross, J. H., Van Emde Boas, W., Engel, J., French, J., Glauser, T. A., Mathern, G. W., et al. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02522.x · Cited by 4,363
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
Dalmau, J., Gleichman, A. J., Hughes, E. G., Rossi, J. E., Peng, X., Lai, M., Dessain, S. K., Rosenfeld, M. R., Balice-Gordon, R., & Lynch, D. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70224-2 · Cited by 3,488
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
Dalmau, J., Lancaster, E., Martinez-Hernandez, E., Rosenfeld, M. R., & Balice-Gordon, R. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70253-2 · Cited by 2,435
Lai, M., Huijbers, M. G., Lancaster, E., Graus, F., Bataller, L., Balice-Gordon, R., Cowell, J. K., & Dalmau, J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70137-x · Cited by 1,361
Irani, S. R., Alexander, S., Waters, P., Kleopa, K. A., Pettingill, P., Zuliani, L., Peles, E., Buckley, C., Lang, B., & Vincent, A. (2010) · Brain · doi:10.1093/brain/awq213 · Cited by 1,359
Vincent, A., Buckley, C., Schott, J. M., Baker, I., Dewar, B., Detert, N., Clover, L., Parkinson, A., Bien, C. G., Omer, S., et al. (2004) · Brain · doi:10.1093/brain/awh077 · Cited by 1,038
Irani, S. R., Bera, K., Waters, P., Zuliani, L., Maxwell, S., Zandi, M. S., Friese, M. A., Galea, I., Kullmann, D. M., Beeson, D., et al. (2010) · Brain · doi:10.1093/brain/awq113 · Cited by 1,035
Lancaster, E., Lai, M., Peng, X., Hughes, E., Constantinescu, R., Raizer, J., Friedman, D., Skeen, M. B., Grisold, W., Kimura, A., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70324-2 · Cited by 928
Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis
Irani, S. R., Michell, A. W., Lang, B., Pettingill, P., Waters, P., Johnson, M. R., Schott, J. M., Armstrong, R. J. E., S. Zagami, A., Bleasel, A., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22307 · Cited by 928
Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients
Graus, F. (2001) · Brain · doi:10.1093/brain/124.6.1138 · Cited by 897
Paraneoplastic syndromes of the CNS
Dalmau, J., & Rosenfeld, M. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70060-7 · Cited by 873
AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location
Lai, M., Hughes, E. G., Peng, X., Zhou, L., Gleichman, A. J., Shu, H., Matà, S., Kremens, D., Vitaliani, R., Geschwind, M. D., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21589 · Cited by 813
Saiz, A., Blanco, Y., Sabater, L., González, F., Bataller, L., Casamitjana, R., Ramió-Torrentà, L., & Graus, F. (2008) · Brain · doi:10.1093/brain/awn183 · Cited by 623
Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features
Kalachikov, S., Evgrafov, O., Ross, B., Winawer, M., Barker-Cummings, C., Boneschi, F. M., Choi, C., Morozov, P., Das, K., Teplitskaya, E., et al. (2002) · Nature Genetics · doi:10.1038/ng832 · Cited by 617
Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis
Malter, M. P., Helmstaedter, C., Urbach, H., Vincent, A., & Bien, C. G. (2010) · Annals of Neurology · doi:10.1002/ana.21917 · Cited by 514
Potassium channel antibodies in two patients with reversible limbic encephalitis
Buckley, C., Oger, J., Clover, L., Tüzün, E., Carpenter, K., Jackson, M., & Vincent, A. (2001) · Annals of Neurology · doi:10.1002/ana.1097 · Cited by 444
Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody
Thieben, M. J., Lennon, V. A., Boeve, B. F., Aksamit, A. J., Keegan, M., & Vernino, S. (2004) · Neurology · doi:10.1212/01.wnl.0000122648.19196.02 · Cited by 394
Amphiphysin autoimmunity: Paraneoplastic accompaniments
Pittock, S. J., Lucchinetti, C. F., Parisi, J. E., Benarroch, E. E., Mokri, B., Stephan, C. L., Kim, K., Kilimann, M. W., & Lennon, V. A. (2005) · Annals of Neurology · doi:10.1002/ana.20529 · Cited by 369
Disruption of LGI1–linked synaptic complex causes abnormal synaptic transmission and epilepsy
Fukata, Y., Lovero, K. L., Iwanaga, T., Watanabe, A., Yokoi, N., Tabuchi, K., Shigemoto, R., Nicoll, R. A., & Fukata, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914537107 · Cited by 343
Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia
Hart, I. K., Waters, C., Vincent, A., Newland, C., Beeson, D., Pongs, O., Morris, C., & Newsom‐Davis, J. (1997) · Annals of Neurology · doi:10.1002/ana.410410215 · Cited by 315
Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy
Peltola, J., Kulmala, P., Isojärvi, J., Saiz, A., Latvala, K., Palmio, J., Savola, K., Knip, M., Keränen, T., & Graus, F. (2000) · Neurology · doi:10.1212/wnl.55.1.46 · Cited by 296
Clinical spectrum of voltage-gated potassium channel autoimmunity
Tan, K. M., Lennon, V. A., Klein, C. J., Boeve, B. F., & Pittock, S. J. (2008) · Neurology · doi:10.1212/01.wnl.0000312275.04260.a0 · Cited by 281
Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy
Bien, C. G., Urbach, H., Schramm, J., Soeder, B. M., Becker, A. J., Voltz, R., Vincent, A., & Elger, C. E. (2007) · Neurology · doi:10.1212/01.wnl.0000276946.08412.ef · Cited by 235
Serum antibodies in epilepsy and seizure-associated disorders
McKnight, K., Jiang, Y., Hart, Y., Cavey, A., Wroe, S., Blank, M., Shoenfeld, Y., Vincent, A., Palace, J., & Lang, B. (2005) · Neurology · doi:10.1212/01.wnl.0000187129.66353.13 · Cited by 231
Glutamic Acid Decarboxylase Autoimmunity With Brainstem, Extrapyramidal, and Spinal Cord Dysfunction
Pittock, S. J., Yoshikawa, H., Ahlskog, J. E., Tisch, S. H., Benarroch, E. E., Kryzer, T. J., & Lennon, V. A. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.9.1207 · Cited by 231
Hoffmann, L. A., Jarius, S., Pellkofer, H. L., Schueller, M., Krumbholz, M., Koenig, F., Johannis, W., la Fougere, C., Newman, T., Vincent, A., et al. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.118588 · Cited by 205
Diagnostic Value of N-methyl-D-aspartate Receptor Antibodies in Women With New-Onset Epilepsy
Niehusmann, P., Dalmau, J., Rudlowski, C., Vincent, A., Elger, C. E., Rossi, J. E., & Bien, C. G. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.5 · Cited by 180
Autoimmune Dementia: Clinical Course and Predictors of Immunotherapy Response
Flanagan, E. P., McKeon, A., Lennon, V. A., Boeve, B. F., Trenerry, M. R., Tan, K. M., Drubach, D. A., Josephs, K. A., Britton, J. W., Mandrekar, J. N., et al. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0326 · Cited by 177
Irani, S. R., Bien, C. G., & Lang, B. (2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283446f05 · Cited by 164
Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy
Liimatainen, S., Peltola, M., Sabater, L., Fallah, M., Kharazmi, E., Haapala, A., Dastidar, P., Knip, M., Saiz, A., & Peltola, J. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02325.x · Cited by 150
IMMUNOTHERAPY-RESPONSIVE SEIZURE-LIKE EPISODES WITH POTASSIUM CHANNEL ANTIBODIES
Irani, S. R., Buckley, C. J., Vincent, A. C., Cockerell, O. C., Rudge, P., Johnson, M. R., & Smith, S. J. M. (2008) · Neurology · doi:10.1212/01.wnl.0000326572.93762.51 · Cited by 141
Antibodies to voltage-gated potassium and calcium channels in epilepsy
Majoie, M., de Baets, M., Renier, W. O., Lang, B., & Vincent, A. C. (2006) · Epilepsy Research · doi:10.1016/j.eplepsyres.2006.06.003 · Cited by 140
Morvan’s syndrome associated with voltage-gated K channel antibodies
Barber, P. A., Anderson, N. E., & Vincent, A. C. (2000) · Neurology · doi:10.1212/wnl.54.3.771 · Cited by 133
Limbic encephalitis not associated with neoplasm as a cause of temporal lobe epilepsy
Bien, C. G., Schulze‐Bonhage, A., Deckert, M., et al. (2000) · Neurology · doi:10.1212/wnl.55.12.1823 · Cited by 129
Limbic encephalitis: A cause of temporal lobe epilepsy with onset in adult life
Bien, C. G., & Elger, C. E. (2007) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2007.03.011 · Cited by 127
Vincent, A. C., Irani, S. R., & Lang, B. (2010) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32833735fe · Cited by 126
Bien, C. G., & Scheffer, I. E. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03031.x · Cited by 106
McKeon, A. B., Marnane, M., O’Connell, M., Stack, J. P., Kelly, P. J., & Lynch, T. (2007) · Archives of Neurology · doi:10.1001/archneur.64.10.1528 · Cited by 70
Neural Autoantibody Profile of Primary Achalasia
Kraichely, R. E., Farrugia, G., Pittock, S. J., Castell, D. O., & Lennon, V. A. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0838-9 · Cited by 68
IMMUNOTHERAPY-RESPONSIVE DEMENTIAS AND ENCEPHALOPATHIES
McKeon, A. B., Lennon, V. A., & Pittock, S. J. (2010) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000368213.63964.34 · Cited by 58
Irani, S. R., Bien, C. G., & Vincent, A. C. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780199796793.003.0015 · Cited by 9
Role for peroxisome proliferator-activated receptor-gamma in Alzheimer's disease.
van Geel (2001) · Open Repository and Bibliography (University of Luxembourg) · doi:10.1002/1531-8249(20010201)49:2 · Cited by 7
Cited by
Padmanabhan, A., Connelly‐Smith, L., Aqui, N., Balogun, R. A., Klingel, R., Meyer, E., Pham, H. P., Schneiderman, J., Witt, V., Wu, Y., et al. (2019) · Journal of Clinical Apheresis · doi:10.1002/jca.21705 · Cited by 2,230
Schwartz, J., Padmanabhan, A., Aqui, N., Balogun, R. A., Connelly‐Smith, L., Delaney, M., Dunbar, N. M., Witt, V., Wu, Y., & Shaz, B. H. (2016) · Journal of Clinical Apheresis · doi:10.1002/jca.21470 · Cited by 793
Petit-Pedrol, M., Armangue, T., Peng, X., Bataller, L., Cellucci, T., Davis, R., McCracken, L., Martinez-Hernandez, E., Mason, W. P., Kruer, M. C., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70299-0 · Cited by 616
Schwartz, J., Winters, J. L., Padmanabhan, A., Balogun, R. A., Delaney, M., Linenberger, M. L., Szczepiorkowski, Z. M., Williams, M. E., Wu, Y., & Shaz, B. H. (2013) · Journal of Clinical Apheresis · doi:10.1002/jca.21276 · Cited by 603
Irani, S. R., Stagg, C. J., Schott, J. M., Rosenthal, C. R., Schneider, S. A., Pettingill, P., Pettingill, R., Waters, P., Thomas, A., Voets, N. L., et al. (2013) · Brain · doi:10.1093/brain/awt212 · Cited by 437
Metadata
- Authors
- Quek, A. M. L.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2012-05-01
- Volume
- 69
- Issue
- 5
- Pages
- 582
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2110026843
- Cited by
- 359
- References
- 43
- FWCI
- 19.82
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.